These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23478386)

  • 1. Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis.
    Strobel O; Büchler MW
    Nat Rev Gastroenterol Hepatol; 2013 Apr; 10(4):203-5. PubMed ID: 23478386
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
    Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
    Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.
    Choi M; Heilbrun LK; Venkatramanamoorthy R; Lawhorn-Crews JM; Zalupski MM; Shields AF
    Am J Clin Oncol; 2010 Jun; 33(3):257-61. PubMed ID: 19806035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
    Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
    J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
    Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
    Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of FDG-PET/CT imaging during concurrent chemo-radiotherapy in patients with locally advanced pancreatic cancer.
    Bjerregaard JK; Fischer BM; Vilstrup MH; Petersen H; Mortensen MB; Hansen CR; Asmussen JT; Pfeiffer P; Høilund-Carlsen PF
    Acta Oncol; 2011 Nov; 50(8):1250-2. PubMed ID: 21545239
    [No Abstract]   [Full Text] [Related]  

  • 7. PET and PET/CT for pancreatic malignancies.
    Delbeke D; Martin WH
    Surg Oncol Clin N Am; 2010 Apr; 19(2):235-54. PubMed ID: 20159513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
    Myssayev A; Myssayev A; Ideguchi R; Eguchi S; Adachi T; Sumida Y; Tobinaga S; Uetani M; Kudo T
    PLoS One; 2019; 14(1):e0210178. PubMed ID: 30629646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
    Kim J; Quon A; Humke E; Ford JM; Koong AC
    Clin Nucl Med; 2009 May; 34(5):312-3. PubMed ID: 19387214
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?
    Wartski M; Sauvanet A
    Diagn Interv Imaging; 2019 Dec; 100(12):735-741. PubMed ID: 31402332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment.
    Delbeke D; Pinson CW
    J Hepatobiliary Pancreat Surg; 2004; 11(1):4-10. PubMed ID: 15747028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
    Klayton T; Li T; Yu JQ; Keller L; Cheng J; Cohen SJ; Meropol NJ; Scott W; Xu-Welliver M; Konski A
    J Gastrointest Cancer; 2012 Dec; 43(4):612-8. PubMed ID: 22777832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
    Chirindel A; Alluri KC; Chaudhry MA; Wahl RL; Pawlik TM; Herman JM; Subramaniam RM
    AJR Am J Roentgenol; 2015 May; 204(5):1093-9. PubMed ID: 25905947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
    Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
    Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
    Santhosh S; Mittal BR; Bhasin DK; Rana SS; Gupta R; Das A; Nada R
    Ann Nucl Med; 2017 Oct; 31(8):575-581. PubMed ID: 28689356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of positron emission tomography in the management of pancreatic cancer.
    Pakzad F; Groves AM; Ell PJ
    Semin Nucl Med; 2006 Jul; 36(3):248-56. PubMed ID: 16762614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.
    Wang XY; Yang F; Jin C; Guan YH; Zhang HW; Fu DL
    Hepatogastroenterology; 2014 Oct; 61(135):2102-9. PubMed ID: 25722999
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Palmieri LJ; Coriat R
    Diagn Interv Imaging; 2019 Dec; 100(12):731-733. PubMed ID: 31780041
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.